|
Volumn 65, Issue 3, 2015, Pages 306-307
|
The effect of rosuvastatin on platelet-leukocyte interactions in the setting of acute coronary syndrome
|
Author keywords
[No Author keywords available]
|
Indexed keywords
PLACEBO;
ROSUVASTATIN;
FLUOROBENZENE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
PYRIMIDINE DERIVATIVE;
SULFONAMIDE;
ACUTE CORONARY SYNDROME;
CELL INTERACTION;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
DRUG MEGADOSE;
EARLY INTERVENTION;
HUMAN;
LETTER;
LEUKOCYTE;
LEUKOCYTE AGGREGATION;
MAJOR CLINICAL STUDY;
PROSPECTIVE STUDY;
THROMBOCYTE;
THROMBOCYTE ADHESION;
THROMBOCYTE AGGREGATION;
BLOOD;
CELL AGGREGATION;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG EFFECTS;
FLOW CYTOMETRY;
PATHOLOGY;
PHASE 1 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
ACUTE CORONARY SYNDROME;
BLOOD PLATELETS;
CELL AGGREGATION;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
FLOW CYTOMETRY;
FLUOROBENZENES;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
LEUKOCYTES;
PROSPECTIVE STUDIES;
PYRIMIDINES;
SULFONAMIDES;
|
EID: 84921324638
PISSN: 07351097
EISSN: 15583597
Source Type: Journal
DOI: 10.1016/j.jacc.2014.10.047 Document Type: Letter |
Times cited : (12)
|
References (5)
|